IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.280
-0.021 (-6.82%)
At close: Mar 9, 2026, 4:00 PM EDT
0.283
+0.003 (1.00%)
After-hours: Mar 9, 2026, 4:46 PM EDT
IO Biotech Market Cap
IO Biotech has a market cap or net worth of $20.15 million as of March 9, 2026. Its market cap has decreased by -72.20% in one year.
Market Cap
20.15M
Enterprise Value
7.57M
1-Year Change
-72.20%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since the IPO on November 5, 2021, IO Biotech's market cap has decreased from $369.28M to $20.15M, a decrease of -94.54%. That is a compound annual growth rate of -48.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 20.15M | -54.02% |
| Dec 31, 2025 | 43.81M | -27.72% |
| Dec 31, 2024 | 60.61M | -51.06% |
| Dec 29, 2023 | 123.86M | 86.88% |
| Dec 30, 2022 | 66.28M | -64.06% |
| Dec 31, 2021 | 184.42M | -50.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuphoria Therapeutics | 23.29M |
| Skye Bioscience | 23.09M |
| Marker Therapeutics | 23.01M |
| Daré Bioscience | 21.86M |
| Lixte Biotechnology Holdings | 21.26M |
| Polyrizon | 20.90M |
| NanoViricides | 20.72M |
| Lexaria Bioscience | 20.63M |